Skip to main content

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

Holdings in Q4 2025

Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.

Institution overview
Positions
176
+28 vs. Q3 2025
Portfolio value
$5.28B
+$464.1M (+9.6%) vs. Q3 2025
Filed
Feb 17, 2026
SEC
Holdings of Bellevue Group AG in Q4 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
RXRXRecursion Pharmaceuticals, Inc.CL A4,921$20.1K<0.1%−593−10.8%ReducedHistory
NTLAIntellia Therapeutics, Inc.COM2,978$26.8K<0.1%+2,978NewHistory
QCOMQualcomm IncStock209$35.7K<0.1%−238−53.2%ReducedHistory
ORCLOracle CorpStock203$39.6K<0.1%−214−51.3%ReducedHistory
AAgilent Technologies, Inc.COM350$47.6K<0.1%−456−56.6%ReducedHistory
MTDMettler Toledo International IncCOM38$53.0K<0.1%−4−9.5%ReducedHistory
RAREUltragenyx Pharmaceutical Inc.COM2,580$59.3K<0.1%+2,580NewHistory
ORICOric Pharmaceuticals, Inc.COM9,706$79.4K<0.1%+9,706NewHistory
TYRATyra Biosciences, Inc.COM3,143$82.6K<0.1%+3,143NewHistory
ZTSZoetis Inc.Stock729$91.7K<0.1%−143−16.4%ReducedHistory
GMABGenmab A/SSPONSORED ADS3,009$92.7K<0.1%00.0%UnchangedHistory
TRVITrevi Therapeutics, Inc.COM7,603$95.2K<0.1%+7,603NewHistory
OLMAOlema Pharmaceuticals, Inc.COM3,902$97.5K<0.1%+3,902NewHistory
CRSPCRISPR Therapeutics AGNAMEN AKT1,880$98.6K<0.1%+1,880NewHistory
AMRXAmneal Pharmaceuticals, Inc.COM STK CL A7,913$99.7K<0.1%00.0%UnchangedHistory
APLSApellis Pharmaceuticals, Inc.COM4,210$105.8K<0.1%+4,210NewHistory
QUREuniQure N.V.SHS4,763$114.0K<0.1%00.0%UnchangedHistory
DNLIDenali Therapeutics Inc.COM7,138$117.8K<0.1%+7,138NewHistory
CGONCG Oncology, Inc.COM3,095$128.5K<0.1%+3,095NewHistory
TVTXTravere Therapeutics, Inc.COM3,827$146.2K<0.1%+3,827NewHistory
IDYAIDEAYA Biosciences, Inc.COM4,942$170.8K<0.1%+4,942NewHistory
CAICaris Life Sciences, Inc.COM6,418$173.2K<0.1%−3,187−33.2%ReducedHistory
CORCencora, Inc.Stock521$176.0K<0.1%−4,329−89.3%ReducedHistory
ALKSAlkermes plc.SHS6,594$184.5K<0.1%00.0%UnchangedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM4,040$188.1K<0.1%+4,040NewHistory
MRNAModerna, Inc.Stock7,711$227.4K<0.1%−1,630−17.4%ReducedHistory
SMMTSummit Therapeutics Inc.COM14,262$249.4K<0.1%−4,720−24.9%ReducedHistory
TEMTempus AI, Inc.CL A4,776$282.0K<0.1%−237−4.7%ReducedHistory
SNYSanofiSPONSORED ADR5,851$283.5K<0.1%−3,009−34.0%ReducedHistory
GHGuardant Health, Inc.COM3,004$306.8K<0.1%+1,051+53.8%AddedHistory
JDJD.com, Inc.SPON ADS CL A11,000$315.7K<0.1%+11,000NewHistory
EXELExelixis, Inc.COM7,361$322.6K<0.1%00.0%UnchangedHistory
PLNTPlanet Fitness, Inc.CL A3,173$344.2K<0.1%−1,128−26.2%ReducedHistory
GRMNGarmin LtdSHS1,726$350.1K<0.1%−305−15.0%ReducedHistory
CORTCorcept Therapeutics IncCOM10,495$365.2K<0.1%+9,268+755.3%AddedHistory
ACNAccenture plcStock1,500$402.4K<0.1%+1,500NewHistory
ADBEAdobe Inc.Stock1,200$420.0K<0.1%+1,200NewHistory
PLTRPalantir Technologies Inc.Stock2,500$444.4K<0.1%+2,500NewHistory
LULUlululemon athletica inc.Stock2,240$465.5K<0.1%+2,240NewHistory
INCYIncyte CorpCOM4,773$471.4K<0.1%−1,435,913−99.7%ReducedHistory
BLKBlackRock, Inc.Stock450$481.7K<0.1%+450NewHistory
VVisa Inc.Stock1,400$491.0K<0.1%+1,400NewHistory
RPRXRoyalty Pharma plcSHS CLASS A13,201$510.1K<0.1%+240+1.9%AddedHistory
PTCTPTC Therapeutics, Inc.COM6,763$513.7K<0.1%+4,233+167.3%AddedHistory
DOCSDoximity, Inc.CL A11,817$523.3K<0.1%+2,124+21.9%AddedHistory
METAMeta Platforms, Inc.Stock800$528.1K<0.1%+400+100.0%AddedHistory
PGProcter & Gamble CoStock3,900$558.9K<0.1%+3,900NewHistory
iShares Russell 2000 ETF464287655ETF2,300$566.2K<0.1%00.0%Unchanged–
ONCBeOne Medicines Ltd.ADR1,890$574.2K<0.1%−31,907−94.4%ReducedHistory
CYTKCytokinetics IncCOM NEW9,225$586.2K<0.1%+7,125+339.3%AddedHistory
CSCOCisco Systems, Inc.Stock8,000$616.2K<0.1%+8,000NewHistory
MSFTMicrosoft CorpStock1,282$620.0K<0.1%+1,079+531.5%AddedHistory
BIIBBiogen Inc.COM3,565$627.4K<0.1%−648−15.4%ReducedHistory
MAMastercard IncStock1,100$628.0K<0.1%+1,100NewHistory
ANETArista Networks, Inc.Stock4,800$628.9K<0.1%+4,800NewHistory
GOOGLAlphabet Inc.Stock2,066$646.7K<0.1%+984+90.9%AddedHistory
BABAAlibaba Group Holding LtdADR4,700$688.9K<0.1%+4,700NewHistory
MLYSMineralys Therapeutics, Inc.COM19,826$719.5K<0.1%−6,779−25.5%ReducedHistory
NVDANVIDIA CorpStock3,933$733.5K<0.1%+3,231+460.3%AddedHistory
ARWRArrowhead Pharmaceuticals, Inc.COM11,550$766.8K<0.1%+11,550NewHistory
RYTMRhythm Pharmaceuticals, Inc.COM7,504$803.2K<0.1%−1,549−17.1%ReducedHistory
AMZNAmazon Com IncStock3,541$817.3K<0.1%+1,729+95.4%AddedHistory
BLLNBillionToOne, Inc.CL A10,589$866.6K<0.1%+10,589NewHistory
CERTCertara, Inc.COM99,442$876.1K<0.1%+39,995+67.3%AddedHistory
AAPLApple Inc.Stock3,320$902.6K<0.1%+1,711+106.3%AddedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS142,243$981.5K<0.1%+142,243NewHistory
DGXQuest Diagnostics IncCOM7,280$1.26M<0.1%−25,735−77.9%ReducedHistory
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES36,336$1.27M<0.1%+21,725+148.7%AddedHistory
VanEck ETF Trust92189F106GOLD MINERS ETF15,500$1.33M<0.1%−3,000−16.2%Reduced–
LEGNLegend Biotech CorpSPONSORED ADS63,971$1.39M<0.1%−21,005−24.7%ReducedHistory
PFEPfizer IncStock56,847$1.42M<0.1%+45,020+380.7%AddedHistory
LHLabcorp Holdings Inc.Stock5,669$1.42M<0.1%−9,396−62.4%ReducedHistory
PTGXProtagonist Therapeutics, IncCOM16,543$1.44M<0.1%−4,038−19.6%ReducedHistory
CAHCardinal Health IncStock7,669$1.58M<0.1%−8,599−52.9%ReducedHistory
EXASExact Sciences CorpCOM16,062$1.63M<0.1%−236,639−93.6%ReducedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM2,884$1.68M<0.1%+491+20.5%AddedHistory
SIBNSI-BONE, Inc.COM90,331$1.78M<0.1%−208,526−69.8%ReducedHistory
BKDBrookdale Senior Living Inc.COM167,444$1.81M<0.1%+62,779+60.0%AddedHistory
BBIOBridgeBio Pharma, Inc.COM24,111$1.84M<0.1%+3,755+18.4%AddedHistory
UTHRUnited Therapeutics CorpCOM3,895$1.90M<0.1%+1,255+47.5%AddedHistory
EHCEncompass Health CorpCOM19,089$2.03M<0.1%−103,869−84.5%ReducedHistory
SPYSPDR S&P 500 ETF TrustETF3,100$2.11M<0.1%00.0%UnchangedHistory
BBNXBeta Bionics, Inc.COM72,285$2.20M<0.1%+8,002+12.4%AddedHistory
ROIVRoivant Sciences Ltd.SHS108,039$2.34M<0.1%+108,039NewHistory
VKTXViking Therapeutics, Inc.COM68,665$2.42M<0.1%−7,417−9.7%ReducedHistory
INSMINSMED IncCOM PAR $.0113,915$2.42M<0.1%−6,336−31.3%ReducedHistory
AZNAstraZeneca PLCSPONSORED ADR30,431$2.80M0.1%−5,213−14.6%ReducedHistory
OMDAOmada Health, Inc.COM177,897$2.81M0.1%−73,894−29.3%ReducedHistory
ILMNIllumina, Inc.COM22,940$3.01M0.1%−857−3.6%ReducedHistory
KMTSKestra Medical Technologies, Ltd.SHS115,755$3.07M0.1%−12,956−10.1%ReducedHistory
BEAMBeam Therapeutics Inc.COM111,510$3.09M0.1%−2,777,778−96.1%ReducedHistory
PHRPhreesia, Inc.COM183,213$3.10M0.1%−129,844−41.5%ReducedHistory
AVTRAvantor, Inc.COM276,266$3.17M0.1%+172,904+167.3%AddedHistory
NEONeogenomics IncCOM NEW278,286$3.27M0.1%−91,912−24.8%ReducedHistory
BTSGBrightSpring Health Services, Inc.COM92,095$3.45M0.1%−98,429−51.7%ReducedHistory
BMYBristol Myers Squibb CoStock67,082$3.62M0.1%+19,469+40.9%AddedHistory
BMRNBiomarin Pharmaceutical IncCOM65,008$3.86M0.1%−36,025−35.7%ReducedHistory
BNTXBioNTech SESPONSORED ADS43,755$4.17M0.1%+9,800+28.9%AddedHistory
ICLRIcon PLCCOM24,560$4.48M0.1%+313+1.3%AddedHistory
ADPTAdaptive Biotechnologies CorpCOM298,090$4.84M0.1%+129,614+76.9%AddedHistory

Sold out since Q3 2025 (9)

Positions held at the end of Q3 2025 that are gone from this filing.

Positions of Bellevue Group AG sold out since Q3 2025
SecurityClassShares in Q3 2025Value in Q3 2025% of portfolio in Q3 2025History
AGIOAgios Pharmaceuticals, Inc.COM3,714,736$149.1M3.1%History
AKROAkero Therapeutics, Inc.COM2,389,314$113.4M2.4%History
BHVNBiohaven Ltd.COM2,802,853$42.1M0.9%History
HOLXHologic IncCOM247,886$16.7M0.3%History
MGNXMacrogenics IncCOM9,919,992$16.7M0.3%History
BAXBaxter International IncStock68,084$1.55M<0.1%History
BIDUBaidu, Inc.ADR2,000$263.5K<0.1%History
MLTXMoonLake ImmunotherapeuticsCLASS A ORD35,052$251.3K<0.1%History
MRUSMerus N.V.COM825$77.7K<0.1%History